These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7509281)

  • 21. Purification and characterization of recombinant equine infectious anemia virus reverse transcriptase.
    Le Grice SF; Panin M; Kalayjian RC; Richter NJ; Keith G; Darlix JL; Payne SL
    J Virol; 1991 Dec; 65(12):7004-7. PubMed ID: 1719238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a thiobenzimidazolone derivative on DNA strand transfer catalyzed by HIV-1 reverse transcriptase.
    Gopalakrishnan V; Benkovic S
    J Biol Chem; 1994 Feb; 269(6):4110-5. PubMed ID: 7508439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical studies on the reverse transcriptase and RNase H activities from human immunodeficiency virus strains resistant to 3'-azido-3'-deoxythymidine.
    Lacey SF; Reardon JE; Furfine ES; Kunkel TA; Bebenek K; Eckert KA; Kemp SD; Larder BA
    J Biol Chem; 1992 Aug; 267(22):15789-94. PubMed ID: 1379238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification and kinetic characterization of equine infectious anemia virus reverse transcriptase.
    Thomas DA; Furman PA
    Biochem Biophys Res Commun; 1991 Nov; 180(3):1365-71. PubMed ID: 1719980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
    Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
    Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
    Gao HQ; Sarafianos SG; Arnold E; Hughes SH
    J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the inhibition of human immunodeficiency virus type 1 reverse transcriptase DNA polymerase activity by analogs of nevirapine and [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1", 2"-oxathiole-2",2"-dioxide] (TSAO).
    Arion D; Fletcher RS; Borkow G; Camarasa MJ; Balzarini J; Dmitrienko GI; Parniak MA
    Mol Pharmacol; 1996 Nov; 50(5):1057-64. PubMed ID: 8913335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the polymerization kinetics of homodimeric EIAV p51/51 reverse transcriptase implies the formation of a polymerase active site identical to heterodimeric EIAV p66/51 reverse transcriptase.
    Souquet M; Restle T; Krebs R; Le Grice SF; Goody RS; Wöhrl BM
    Biochemistry; 1998 Sep; 37(35):12144-52. PubMed ID: 9724526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit.
    Sevilya Z; Loya S; Adir N; Hizi A
    Nucleic Acids Res; 2003 Mar; 31(5):1481-7. PubMed ID: 12595556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
    Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
    Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of cysteine mutations on the reverse transcriptases of human immunodeficiency virus types 1 and 2.
    Hizi A; Shaharabany M; Tal R; Hughes SH
    J Biol Chem; 1992 Jan; 267(2):1293-7. PubMed ID: 1370463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptases of human immunodeficiency and murine leukemia retroviruses.
    Loya S; Hizi A
    J Biol Chem; 1993 May; 268(13):9323-8. PubMed ID: 7683648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of the chimeric reverse transcriptase of simian immunodeficiency virus sensitive to nonnucleoside reverse transcriptase inhibitor.
    Isaka Y; Sato A; Kawauchi S; Suyama A; Miki S; Hayami M; Fujiwara T
    Microbiol Immunol; 1998; 42(3):195-202. PubMed ID: 9570285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous mutations at Tyr-181 and Tyr-188 in HIV-1 reverse transcriptase prevents inhibition of RNA-dependent DNA polymerase activity by the bisheteroarylpiperazine (BHAP) U-90152s.
    Fan N; Rank KB; Evans DB; Thomas RC; Tarpley WG; Sharma SK
    FEBS Lett; 1995 Aug; 370(1-2):59-62. PubMed ID: 7544302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutagenesis of cysteine 280 of the reverse transcriptase of human immunodeficiency virus type-1: the effects on the ribonuclease H activity.
    Sevilya Z; Loya S; Duvshani A; Adir N; Hizi A
    J Mol Biol; 2003 Mar; 327(1):19-30. PubMed ID: 12614605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli.
    Hizi A; Tal R; Hughes SH
    Virology; 1991 Jan; 180(1):339-46. PubMed ID: 1701948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance of human immunodeficiency virus type 1 reverse transcriptase to TIBO derivatives induced by site-directed mutagenesis.
    de Vreese K; Debyser Z; Vandamme AM; Pauwels R; Desmyter J; de Clercq E; Anné J
    Virology; 1992 Jun; 188(2):900-4. PubMed ID: 1374986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the integrases of human immunodeficiency viruses type 1 and type 2 by reverse transcriptases.
    Oz I; Avidan O; Hizi A
    Biochem J; 2002 Feb; 361(Pt 3):557-66. PubMed ID: 11802785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.
    Sardana VV; Emini EA; Gotlib L; Graham DJ; Lineberger DW; Long WJ; Schlabach AJ; Wolfgang JA; Condra JH
    J Biol Chem; 1992 Sep; 267(25):17526-30. PubMed ID: 1381350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active site studies of human immunodeficiency virus reverse transcriptase.
    Mitchell LL; Cooperman BS
    Biochemistry; 1992 Aug; 31(33):7707-13. PubMed ID: 1380826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.